Discontinued — last reported Q4 '25
Other Investing
InvestingEli Lilly Other Investing decreased by 283.2% to -$56.80M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 135.8%, from $158.80M to -$56.80M. Over 3 years (FY 2021 to FY 2025), Other Investing shows an upward trend with a -65.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryOther
SignalContext dependent
VolatilityVolatile
First reportedQ4 2014
Last reportedQ4 2025
How to read this metric
Usually represents minor adjustments; however, large values should be scrutinized for one-time asset disposals or unusual investment activities.
Detailed definition
A category capturing miscellaneous cash flows from investing activities that do not fall under capital expenditures, acq...
Peer comparison
Standard across most corporate cash flow statements as a balancing category for non-core investing movements.
Metric ID:
cf_other_investingHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$72.40M | $53.20M | -$27.00M | $133.40M | -$22.10M | $157.00M | -$40.30M | -$456.80M | $666.20M | $22.80M | $65.20M | -$95.60M | $169.80M | $158.80M | -$39.30M | $64.10M | $31.00M | -$56.80M |
| QoQ Change | — | +173.5% | -150.8% | +594.1% | -116.6% | +810.4% | -125.7% | <-999% | +245.8% | -96.6% | +186.0% | -246.6% | +277.6% | -6.5% | -124.7% | +263.1% | -51.6% | -283.2% |
| YoY Change | — | — | — | — | +69.5% | +195.1% | -130.2% | <-999% | +324.3% | — | +261.8% | +79.1% | -74.5% | +596.5% | -160.3% | +167.1% | -81.7% | -135.8% |
Range-$456.80M – $666.20M
CAGR-5.5%
Avg YoY Growth-65.9%
Median YoY Growth+69.5%
Current Streak2 quarters decline
Other Investing at Other Companies
Frequently Asked Questions
- What is Eli Lilly's other investing?
- Eli Lilly (LLY) reported other investing of -$56.80M in Q4 2025.
- How has Eli Lilly's other investing changed year-over-year?
- Eli Lilly's other investing decreased by 135.8% year-over-year, from $158.80M to -$56.80M.
- What is the long-term trend for Eli Lilly's other investing?
- Over 3 years (2021 to 2025), Eli Lilly's other investing has grown at a -65.5% compound annual growth rate (CAGR), from -$24.30M to -$1.00M.
- What does other investing mean?
- Miscellaneous cash transactions related to long-term investments or asset sales not covered in other categories.